IQVIA Holdings Inc. (NYSE: IQV) Stock Analysis & Fundamentals | ScreenerHero

Create free account

IQVIQVIA Holdings Inc.

NYSE · US · Healthcare · Diagnostics & Research · iqvia.com

233.37USD-0.70%Mkt Cap: 38.41B $P/E: 29.021d ago

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates …

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$213.32BUSDP/E 30.8

Danaher Corporation

$138.84BUSDP/E 35.1

$44.66BUSDP/E 36.1

IDEXX Laboratories, Inc.

$44.79BUSDP/E 41.8

Agilent Technologies, Inc.

$39.48BUSDP/E 28.1

Waters Corporation

$36.79BUSDP/E 47.7

$29.98BUSDP/E 37.0

Mettler-Toledo International Inc.

$29.20BUSDP/E 32.6

Quest Diagnostics Incorporated

$25.60BUSDP/E 24.6

Labcorp Holdings Inc.

$24.87BUSDP/E 25.4

Guardant Health, Inc.

Medpace Holdings, Inc.

$16.00BUSDP/E 33.7

Eurofins Scientific SE

$12.72BUSDP/E 23.5

$12.85BUSDP/E 55.4

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.26BUSDP/E 18.5

BillionToOne, Inc.

$6.32BUSDP/E 254.3

Twist Bioscience Corporation

Sotera Health Company

$5.13BUSDP/E 43.9

DiaSorin S.p.A.

$4.04BUSDP/E 28.5

Adaptive Biotechnologies Corporation

$3.58BUSDP/E 32.0

$2.48BUSDP/E 23.0

NeoGenomics, Inc.

GeneDx Holdings Corp.

Vimian Group AB (publ)

$1.76BUSDP/E 45.1

Diagnostyka S.A.

$1.43BUSDP/E 21.7

Personalis, Inc.

Clínica Baviera, S.A.

$1.06BUSDP/E 21.2

OPKO Health, Inc.

Castle Biosciences, Inc.

$639.18MUSDP/E 41.6

Fulgent Genetics, Inc.

$335.15MUSDP/E 3.4

Spectral Medical Inc.

Myriad Genetics, Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Biomark Diagnostics Inc.

Abingdon Health Plc

Immunovia AB (publ)

Izotropic Corporation

Proteome Sciences plc

Oxford BioDynamics Plc

ENDRA Life Sciences Inc.

Avricore Health Inc.

Leveljump Healthcare Corp.

bioAffinity Technologies, Inc.

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap38.41B $

Enterprise Value52.99B $

Revenue (TTM)16.98B $

Gross Profit5.43B $

Net Income (TTM)1.36B $

Revenue/Share100.70 USD

Last Price233.37 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees94.0K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINUS46266C1053

Valuation

P/E (Trailing)29.02

P/E (Forward)16.29

PEG0.97

EV/EBITDA17.39

EV/Revenue3.12

P/S2.28

P/B6.27

EPS (TTM)8.04

EPS (Forward)14.43

52W Range

154.5081% of range251.35

52W High251.35 USD

52W Low154.50 USD

Profitability

Gross Margin33.29%

Oper. Margin13.03%

EBITDA Margin17.95%

Profit Margin8.34%

ROE20.91%

ROA4.54%

Growth

Revenue Growth8.70%

Earnings Growth-0.60%

Cash Flow & Leverage

Operating CF2.65B $

CapEx (TTM)603.00M $

FCF Margin12.66%

FCF Yield5.60%

Net Debt14.17B $

Net Debt/EBITDA4.65

Balance Sheet

Debt/Equity2.14

Current Ratio0.71

Quick Ratio0.62

Book Value/Sh37.49 USD

Cash/Share12.64 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.4 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)272.94 USD

Upside (mean)+17.0%

Target Range240.00 USD – 300.00 USD

$240.00+17.0% to mean$300.00

# Analysts18

Ownership

Shares Out.164.60M

Float156.25M

Insiders1.09%

Institutions104.75%

Short Interest

Short Ratio3.4d

Short % Float3.65%

Short % Out.3.15%

Shares Short5.26M

Short (prev mo.)5.03M

Technical

SMA 50193.95 (+20.3%)

SMA 200197.46 (+18.2%)

Beta1.20

S&P 52W Chg18.32%

Avg Vol (30d)1.24M

Avg Vol (10d)1.78M

Technical Indicators

RSI (14)66.3

MACD11.7511

MACD Signal9.4927

MACD Hist.+2.2583

BB Upper245.14 USD

BB Middle214.89 USD

BB Lower184.63 USD

BB Width28.16%

ATR (14)8.838 USD

Vol Ratio (20d)1.11x